Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival.

Journal of gastrointestinal cancer - 1 Mar 2023

Fleming Christina A, Mohan Helen M, O'Leary Donal P, Corrigan Mark, Redmond H Paul

Abstract excerpt

PURPOSE: Metabolomic analysis in colorectal cancer (CRC) is an emerging research area with both prognostic and therapeutic targeting potential. We aimed to identify metabolomic pathway activity prognostic for CRC recurrence and overall survival and cross-reference such metabolomic data with prognostic genomic single-nucleotide polymorphisms (SNPs). METHODS: A systematic search of PubMed, Embase and Cochrane...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ammonia
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Metabolomics

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Identifiers

PMID: 35239102
DOI: 10.1007/s12029-022-00813-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival.PMID 35239102Read ↗

Metabolomic markers of colorectal tumor with different clinicopathological featuresSemantic proximity Read ↗

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancerSemantic proximity Read ↗

Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinomaSemantic proximity Read ↗

Metabolomic analysis reveals key changes in amino acid metabolism in colorectal cancer patientsSemantic proximity Read ↗

A Multiomic Approach Integrating Genomic and Metabolomic Data Highlights Colorectal Cancer Pathways.Semantic proximity Read ↗

A predictive assay for chemotherapeutic efficacy of stage IV colorectal cancer using serum metabolic features profilingSemantic proximity Read ↗

Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic ModelingSemantic proximity Read ↗

Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival.Semantic proximity Read ↗

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkersSemantic proximity Read ↗

One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.Semantic proximity Read ↗

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.Semantic proximity Read ↗

Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.